Dermatan Sulfate Domains Defined by the Novel Antibody GD3A12, in Normal Tissues and Ovarian Adenocarcinomas

Overview

Journal Histochem Cell Biol

Publisher Springer

Specialties Biochemistry
Cell Biology

Date 2009 Apr 11

PMID 19360434

Citations 20

Authors

Gerdy B Ten Dam

Shuhei Yamada

Fumi Kobayashi

Anurag Purushothaman

Els M A van de Westerlo

Johan Bulten

Anders Malmstrom

Kazuyuki Sugahara

Leon F Massuger

Toin H van Kuppevelt

Affiliations

Soon will be listed here.

Abstract

Dermatan sulfate (DS) expression in normal tissue and ovarian cancer was investigated using the novel, phage display-derived antibody GD3A12 that was selected against embryonic glycosaminoglycans (GAGs). Antibody GD3A12 was especially reactive with DS rich in IdoA-GalNAc4S disaccharide units. IdoA residues are important for antibody recognition as DS polymers with low numbers of IdoA residues were less reactive, and expression of the DS epimerase in ovarian carcinoma cells was associated with expression of the GD3A12 epitope. Moreover, staining of antibody GD3A12 was abolished by chondroitinase-B lyase digestion. Expression of DS domains defined by antibody GD3A12 was confined to connective tissue of most organs examined and presented as a typical fibrillar-type of staining. Differential expression of the DS epitopes recognized by antibodies GD3A12 and LKN1 (4/2,4 di-O-sulfated DS) was best seen in thymus and spleen, indicating differential expression of various DS domains in these organs. In ovarian carcinomas strong DS expression was found in the stromal parts, and occasionally on tumor cells. Partial co-localization in ovarian carcinomas was observed with decorin, versican and type I collagen suggesting a uniform distribution of this specific DS epitope. This unique anti-DS antibody may be instrumental to investigate the function, expression, and localization of specific DS domains in health and disease.

Citing Articles

Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects.

Wolters-Eisfeld G, Oliveira-Ferrer L Semin Immunopathol. 2024; 46(6):16.

PMID: 39432076 PMC: 11493797. DOI: 10.1007/s00281-024-01025-6.

Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens.

Khan Khilji S, Op t Hoog C, Warschkau D, Luhle J, Goerdeler F, Freitag A Theranostics. 2023; 13(9):3041-3063.

PMID: 37284439 PMC: 10240822. DOI: 10.7150/thno.80901.

Histories of Dermatan Sulfate Epimerase and Dermatan 4--Sulfotransferase from Discovery of Their Enzymes and Genes to Musculocontractural Ehlers-Danlos Syndrome.

Mizumoto S, Yamada S Genes (Basel). 2023; 14(2).

PMID: 36833436 PMC: 9957132. DOI: 10.3390/genes14020509.

The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.

Mizumoto S, Yamada S Int J Mol Sci. 2022; 23(13).

PMID: 35806490 PMC: 9267682. DOI: 10.3390/ijms23137485.

An Overview of Functions of Chondroitin Sulfate and Dermatan Sulfate Revealed by Their Deficient Mice.

Mizumoto S, Yamada S Front Cell Dev Biol. 2021; 9:764781.

PMID: 34901009 PMC: 8652114. DOI: 10.3389/fcell.2021.764781.

References

Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I . Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol. 2002; 12(3):173-86. DOI: 10.1016/S1044-579X(02)00021-4. View

Sugahara K, Nadanaka S, Takeda K, Kojima T . Structural analysis of unsaturated hexasaccharides isolated from shark cartilage chondroitin sulfate D that are substrates for the exolytic action of chondroitin ABC lyase. Eur J Biochem. 1996; 239(3):871-80. DOI: 10.1111/j.1432-1033.1996.0871u.x. View

Skandalis S, Kletsas D, Kyriakopoulou D, Stavropoulos M, Theocharis D . The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta. 2006; 1760(8):1217-25. DOI: 10.1016/j.bbagen.2006.03.021. View

Tovar A, de Mattos D, Stelling M, Sarcinelli-Luz B, Nazareth R, Mourao P . Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Biochim Biophys Acta. 2005; 1740(1):45-53. DOI: 10.1016/j.bbadis.2005.02.008. View

Bao X, Pavao M, Dos Santos J, Sugahara K . A functional dermatan sulfate epitope containing iduronate(2-O-sulfate)alpha1-3GalNAc(6-O-sulfate) disaccharide in the mouse brain: demonstration using a novel monoclonal antibody raised against dermatan sulfate of ascidian Ascidia nigra. J Biol Chem. 2005; 280(24):23184-93. DOI: 10.1074/jbc.M503036200. View

Ten Dam G, van de Westerlo E, Purushothaman A, Stan R, Bulten J, Sweep F . Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am J Pathol. 2007; 171(4):1324-33. PMC: 1988881. DOI: 10.2353/ajpath.2007.070111. View

Iozzo R . Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem. 1998; 67:609-52. DOI: 10.1146/annurev.biochem.67.1.609. View

Li F, Yamada S, Basappa , Shetty A, Sugiura M, Sugahara K . Determination of iduronic acid and glucuronic acid in sulfated chondroitin/dermatan hybrid chains by (1)H-nuclear magnetic resonance spectroscopy. Glycoconj J. 2008; 25(7):603-10. DOI: 10.1007/s10719-008-9124-x. View

Theocharis A, Vynios D, Papageorgakopoulou N, Skandalis S, Theocharis D . Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol. 2003; 35(3):376-90. DOI: 10.1016/s1357-2725(02)00264-9. View

10.

Shirk R, Parthasarathy N, San Antonio J, Church F, Wagner W . Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem. 2000; 275(24):18085-92. DOI: 10.1074/jbc.M001659200. View

11.

Trowbridge J, Gallo R . Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology. 2002; 12(9):117R-25R. DOI: 10.1093/glycob/cwf066. View

12.

Wegrowski Y, Maquart F . Involvement of stromal proteoglycans in tumour progression. Crit Rev Oncol Hematol. 2004; 49(3):259-68. DOI: 10.1016/j.critrevonc.2003.10.005. View

13.

Hikino M, Mikami T, Faissner A, Vilela-Silva A, Pavao M, Sugahara K . Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain. J Biol Chem. 2003; 278(44):43744-54. DOI: 10.1074/jbc.M308169200. View

14.

Bao X, Mikami T, Yamada S, Faissner A, Muramatsu T, Sugahara K . Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains. J Biol Chem. 2005; 280(10):9180-91. DOI: 10.1074/jbc.M413423200. View

15.

Pavao M, Mourao P, Mulloy B, Tollefsen D . A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity. J Biol Chem. 1995; 270(52):31027-36. DOI: 10.1074/jbc.270.52.31027. View

16.

Jenniskens G, Oosterhof A, Brandwijk R, Veerkamp J, van Kuppevelt T . Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci. 2000; 20(11):4099-111. PMC: 6772625. View

17.

Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H . Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol. 2003; 13(5):612-20. DOI: 10.1016/j.sbi.2003.09.011. View

18.

Ten Dam G, Kurup S, van de Westerlo E, Versteeg E, Lindahl U, Spillmann D . 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem. 2005; 281(8):4654-62. DOI: 10.1074/jbc.M506357200. View

19.

Skandalis S, Theocharis A, Papageorgakopoulou N, Vynios D, Theocharis D . The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie. 2006; 88(9):1135-43. DOI: 10.1016/j.biochi.2006.03.011. View

20.

Miller M, Costello C, Malmstrom A, Zaia J . A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms. Glycobiology. 2006; 16(6):502-13. PMC: 2577607. DOI: 10.1093/glycob/cwj093. View